diagnogene

The company

Diagnogene is a Swiss company specialized in medical diagnostics.

Genetic diagnostics:

We propose a large panel of over 600 molecular tests including prenatal diagnostics, genetic predispositions, and pharmacogenomics. Developing analyses upon request and offering frequent as well as rare genetic disorders, we cover a wide area of the molecular genetic and cytogenetic diagnostic fields.

Our analyses which fulfill highest standard quality requirements are done in laboratories located in Europe and USA. The network allows the centralization of analyses, processing in batches, and reduction of costs as well as a better geographical distribution of the diagnostics at affordable prices. An ideal partner for laboratories, Diagnogene offers direct contact with the physician as well through blood spots and saliva-based tests.

We aim to improve the quality and availability of genetic testing by developing a comprehensive panel of genetic analyses.

Diagnostic devices:

Diagnogene is working on the co-development and commercialization of diagnostic devices in partnership with leading specialists. Our goal is to provide reliable, easy-to-use and cost-effective devices, with a broad spectrum of actionable applications. Our first device, the EDELSCAN, is a revolutionary bio-sensor that measures the antioxidant activity of a variety of samples, including biological fluids in 20 seconds.

 

 

EDEL THERAPEUTICS SA, based in Lausanne, Switzerland, the developer and manufacturer of the EDELSCAN device, a revolutionary bio-sensor that measures the antioxidant activity of a variety of samples, including biological fluids in 20 seconds and DIAGNOGENE have concluded an agreement for the commercial development of the EDELSCAN

DIAGNOGENE will be responsible for business development, and is the official business representative of EDEL THERAPEUTICS.

SINGLE GENES FULL SEQUENCING

650 EUR per sample per gene - 550 EUR per sample for 100 prepaid:

-Breast and Ovarian cancer (BRCA1)
-Breast and Ovarian cancer (BRCA2)
-Adenomatosous polyposis of the colon (APC)
-Hereditary Non Polyposis Colon Cancer (MLH1)
-Hereditary Non Polyposis Colon Cancer (MSH2)

BRCA AND HNPCC TESTS (EMQN CERTIFIED)

1200 EUR per test - 990 EUR per sample for 100 pre-paid - 890 EUR per sample for 1000 prepaid:
-BRCA 1 and BRCA 2 full genes screening
-MSH2, MLH1 and MSH6 full genes screening

Technique used

SPECIFIC MUTATIONS IN FREQUENT DISORDERS

-Cystic fibrosis (CF) 33 mutations + poly T
155 EUR per sample, 105 EUR per sample for 200 prepaid
-Thrombophilia, Factor V Leiden (R506Q)
55 EUR per test, 39 EUR per sample for 200 prepaid
-Thrombophilia, Prothrombin - Factor II - (G20210Av)
55 EUR per test, 39 EUR per sample for 200 prepaid
-Hemochromatosis (C282 Y, H63D)
80 per test, 49 EUR per sample for 200 prepaid